Gaudio, M.
Jacobs, F.
Benvenuti, C.
Saltalamacchia, G.
Gerosa, R.
De Sanctis, R. http://orcid.org/0000-0003-3202-1933
Santoro, A.
Zambelli, A.
Article History
Received: 18 July 2023
Accepted: 29 September 2023
First Online: 4 November 2023
Declarations
:
: R.D.S.: Lilly, Novartis, Istituto Clinico Gentili, Amgen, EISAI, and Ipsen; all disclosures are outside the submitted work. A.S.: Bristol Myers Squibb, Servier, Gilead Sciences, Pfizer, Eisai, Bayer, MSD, Sanofi, Incyte. Speakers' Bureau: Takeda, Roche, AbbVie, Amgen, Celgene, AstraZeneca, Lilly, Sandoz, Novartis, BMS, Servier, Gilead Sciences, Pfizer, Eisai, Bayer, MSD, ArQule; all disclosures are outside the submitted work. A.Z.: Novartis, AstraZeneca, Lilly, Pfizer, Daiichi Sankyo, MDS (Merck Sharp&Dome), Roche, Seagen, Exact Sciences, Gilaed, Istituto Gentili; all disclosures are outside the submitted work. M.G., F.J., C.B., G.S., and R.G. have no conflict of interest to declare.